January 8, 2021 -- The U.K.'s Medicines and Healthcare products Regulatory Agency approved Moderna's messenger RNA (mRNA) COVID-19 vaccine, mRNA-1273, for use under Regulation 174.
The temporary authorization permits the supply of the COVID-19 vaccine in Great Britain. The U.K. government purchased an additional 10 million doses of the Moderna vaccine, bringing its confirmed order commitment to 17 million doses. The first U.K. deliveries of the vaccine will commence early this year, Moderna said.
The U.K. is the fifth jurisdiction to authorize Moderna's COVID-19 vaccine, following the U.S., Canada, Israel, and the European Union. Additional authorizations are currently under review in a number of countries such as Singapore and Switzerland, the firm said.